February 1, 2018: In the Know

Want the weekly news delivered directly to your inbox? Sign up for the MAA newsletter and stay In The Know 

1. Upsher-Smith Receives FDA Approval For Bumetanide Tablets, USP
2. Nonprofit MDI adds “white room” work to its industrial portfolio
3. Recovery Force and Mayo Clinic collaborate on Wearable Med-Tech Garments
4. Abbott: ‘Top Innovator’ with 20 Breakthroughs
5. Takeda’s Zika vaccine gets U.S. FDA’s ‘fast track’ status
6. Rochester Economic Development Fund Brings Millions of Dollars and is Key to Job Creation
7. Medtronic, Philips ink LungGPS lung cancer treatment dev deal
8. Humanetics Corporation Presents Data on Drug to Protect Cardiac Cells Against Toxicity From Space-Like Radiation
9. 3M and 3Shape Partner to Advance Digital Workflows for Orthodontics
10. Sun Biopharma, Inc. Announces Initiation of First-Line Combination Study of Sbp-101 With Gemcitabine and Nab-Paclitaxel in Patients With Pancreatic Cancer
11. CONGRESS PASSES TWO-YEAR SUSPENSION ON MEDICAL DEVICE EXCISE TAX, AGAIN
12. Bio-Techne’s Ella™ Added to BioAgilytix Portfolio of Industry-Leading Immunoassay Platforms
13. Cardiovascular Systems hires Medtronic executive as its new COO
14. St. Jude Medical delivers sales growth for Abbott Labs
15. IoT Gives Minnesota Companies a ‘Smart’ Way to Do Business
16. BrainCheck, Player’s Health Partner to Better Protect Young Athletes